Osaic Holdings
STML

Osaic Holdings’s Stemline Therapeutics, Inc. STML Stock Holding History

Osaic Holdings’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-180
Closed – – 6514
2020
Q1 		$0 Buy
+180
New +$1.17K ﹤0.01% 6302

Osaic Holdings's STML Position: Q2 2020 in Review

Osaic Holdings sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 180 shares.

Osaic Holdings first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Osaic Holdings reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Osaic Holdings sold 180 Stemline Therapeutics, Inc. shares in Q2 2020.
  • Osaic Holdings first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Osaic Holdings's Stemline Therapeutics, Inc. position peaked at $0 in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Osaic Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.